Skip to main content

McAdam, LLC

Position in PFE — Pfizer Inc

CIK 1695490 Philadelphia, PA

Position in PFE

as of Jun 30, 2026 · filed Aug 4, 2026
Position Value
$661,140
+$73,342 QoQ
Shares Held
27,456
+31.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#1,568
of 2,821 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in PFE Over Time

Shares Held

Position Value (USD)

Derivatives in PFE

reported options exposure · as of Dec 31, 2020
CallValue
$25,767
CallShares
700
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

McAdam, LLC holds $23,291,732 across 9 Drug Manufacturers - General names. PFE ranks #6 (2.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
6 PFE
Pfizer Inc
This page
27,456 $661,140

All Filings in PFE

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $661,140 27,456
2026-03-31 $587,798 20,933
2025-12-31 $567,371 22,786
2025-09-30 $369,969 14,520
2025-06-30 $331,457 13,674
2025-03-31 $328,609 12,968
2024-12-31 $547,446 20,635
2024-09-30 $623,165 21,533
2024-06-30 $528,961 18,905
2024-03-31 $429,764 15,487
2023-12-31 $432,397 15,019
2023-09-30 $462,920 13,956
2023-06-30 $474,089 12,925
2023-03-31 $509,714 12,493
2022-12-31 $521 8,827
2022-09-30 $447,095 10,217
2022-06-30 $538,875 10,278
2022-03-31 $458,578 8,858
2021-12-31 $521,234 8,827
2021-09-30 $264,597 6,152
2021-06-30 $236,448 6,038
2020-12-31 $25,767 700
2020-12-31 $233,743 6,350
2020-09-30 $392,946 10,707
2020-06-30 $282,626 8,643
2020-03-31 $234,713 7,191